personalized tirzepatide Compounded Transform your wellness journey with

Simply put: A 220-lb body requires more energy than a 180-lb body

If development started today, oral tirzepatide would likely require 6-11 years to reach FDA approval (typical pharmaceutical development timeline)

Tirzepatide differs from GLP-1RAs in that, in addition to agonizing the GLP-1R, this drug also acts as a GIPR agonist, providing direct effects on white adipose tissue that may further benefit MASH histology beyond glycemic control and weight loss [52]

For patients interested in more pronounced weight loss benefits, contact us to see if increasing your dose is right for you

Zepbound vs Wegovy and Saxenda While clinical trials have demonstrated Zepbound to be the most effective GLP-1 for weight-loss yet, it's not your only option

Additionally, cannabis may interact with the bodys endocannabinoid system, which is involved in regulating energy storage and expenditure